Nova Biomedical Corp was awarded a firm fixed price purchase order totaling $186,632 by the Department of Health and Human Services Food and Drug Administration to deliver a nutrient analyzer as requested in Solicitation Number HHS-FDA-20-SOL-12345 issued on June 16, 2020. The purchase order does not include any set aside provisions. Performance will occur at the agency's Silver Spring, Maryland location through the period of September 23, 2025. Nova Biomedical is a manufacturer and distributor of in vitro diagnostic equipment and clinical laboratory instruments. The award draws from Nova Biomedical's expertise and will support the FDA's efforts to analyze nutrients through its labs.
Generated 3/9/24, 9:23 AM